Azitra, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Azitra, Inc. (AZTR) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of -$14.51 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-02-27
- Azitra, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was -$14.51K, a 113.73% decline from fiscal 2024.
- Azitra, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $105.72K, a 89.98% increase from fiscal 2023.
- Azitra, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $55.65K, a 37.73% decline from fiscal 2022.
- Azitra, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $89.37K.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$14.51K 10-K · filed 2026-02-27 | |
| 2024-12-31 | $105.72K 10-K · filed 2026-02-27 | |
| 2023-12-31 | $55.65K 10-K · filed 2025-02-24 | $48.34K 10-K · filed 2024-03-15 |
| 2022-12-31 | $89.37K 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |